Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Flexible-Dose Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Conditions
Interventions
Aripiprazole
Placebo
Locations
39
United States
Little Rock, Arkansas, United States
Sacramento, California, United States
Santa Ana, California, United States
Wildomar, California, United States
Hialeah, Florida, United States
Orange City, Florida, United States
Start Date
July 27, 2011
Primary Completion Date
November 6, 2013
Completion Date
November 6, 2013
Last Updated
October 7, 2021
NCT02864589
NCT01585207
NCT01727713
NCT00706589
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions